Thrombocytopenia [clinicaltrials_resource:78f621b96ba366d93bd454d319499b20]
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine [clinicaltrials:NCT00001533]Screening for Hematology Branch Protocols [clinicaltrials:NCT00001620]Treatment of Autoimmune Thrombocytopenia (AITP) [clinicaltrials:NCT00001630]clinicaltrials:NCT00002665Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [clinicaltrials:NCT00003619]Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00004215]Stem Cell Transplantation (SCT) for Genetic Diseases [clinicaltrials:NCT00004378]Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00004787]Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [clinicaltrials:NCT00012376]Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus [clinicaltrials:NCT00015639]clinicaltrials:NCT00031980Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00037791]Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin [clinicaltrials:NCT00039858]Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00039910]Daclizumab to Treat Chronic Immune Thrombocytopenia [clinicaltrials:NCT00049725]Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) [clinicaltrials:NCT00073580]clinicaltrials:NCT00074165clinicaltrials:NCT00075387AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [clinicaltrials:NCT00102323]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [clinicaltrials:NCT00102336]SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [clinicaltrials:NCT00110799]clinicaltrials:NCT00116688Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children [clinicaltrials:NCT00118664]clinicaltrials:NCT00128713Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma [clinicaltrials:NCT00151866]Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [clinicaltrials:NCT00239733]clinicaltrials:NCT00260689Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days [clinicaltrials:NCT00261924]Safety and Performance of MIRASOLĀ® PRT Treated Platelet Transfusion Products [clinicaltrials:NCT00263809]clinicaltrials:NCT00283439clinicaltrials:NCT00303472Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission [clinicaltrials:NCT00305708]clinicaltrials:NCT00321711Mechanism of Thrombocytopenia in Infants [clinicaltrials:NCT00333333]Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide [clinicaltrials:NCT00358540]clinicaltrials:NCT00413283clinicaltrials:NCT00415532clinicaltrials:NCT00418665Strategies for Transfusion of Platelets (SToP) [clinicaltrials:NCT00420914]clinicaltrials:NCT00454857
condition [clinicaltrials_vocabulary:condition]
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine [clinicaltrials:NCT00001533]Screening for Hematology Branch Protocols [clinicaltrials:NCT00001620]Treatment of Autoimmune Thrombocytopenia (AITP) [clinicaltrials:NCT00001630]clinicaltrials:NCT00002665Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [clinicaltrials:NCT00003619]Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00004215]Stem Cell Transplantation (SCT) for Genetic Diseases [clinicaltrials:NCT00004378]Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00004787]Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [clinicaltrials:NCT00012376]Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus [clinicaltrials:NCT00015639]clinicaltrials:NCT00031980Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00037791]Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00038311]Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin [clinicaltrials:NCT00039858]Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00039910]Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) [clinicaltrials:NCT00043940]Daclizumab to Treat Chronic Immune Thrombocytopenia [clinicaltrials:NCT00049725]Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) [clinicaltrials:NCT00073580]clinicaltrials:NCT00074165clinicaltrials:NCT00075387AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [clinicaltrials:NCT00102323]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [clinicaltrials:NCT00102336]SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy [clinicaltrials:NCT00102726]SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [clinicaltrials:NCT00110799]clinicaltrials:NCT00116688Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children [clinicaltrials:NCT00118664]clinicaltrials:NCT00128713Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma [clinicaltrials:NCT00151866]A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia [clinicaltrials:NCT00194987]The HIT-TRAP Trial [clinicaltrials:NCT00196417]A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients [clinicaltrials:NCT00198575]Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia [clinicaltrials:NCT00198588]A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia [clinicaltrials:NCT00220311]Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [clinicaltrials:NCT00239733]clinicaltrials:NCT00244010clinicaltrials:NCT00260689Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days [clinicaltrials:NCT00261924]Safety and Performance of MIRASOLĀ® PRT Treated Platelet Transfusion Products [clinicaltrials:NCT00263809]Heparin Antibodies in Intensive Care Unit Patients (HAICU) [clinicaltrials:NCT00283322]clinicaltrials:NCT00283439
condition browse [clinicaltrials_vocabulary:condition-browse]
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine [clinicaltrials:NCT00001533]Screening for Hematology Branch Protocols [clinicaltrials:NCT00001620]Treatment of Autoimmune Thrombocytopenia (AITP) [clinicaltrials:NCT00001630]clinicaltrials:NCT00002665Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [clinicaltrials:NCT00003619]Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00004215]Stem Cell Transplantation (SCT) for Genetic Diseases [clinicaltrials:NCT00004378]Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00004787]Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [clinicaltrials:NCT00012376]Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus [clinicaltrials:NCT00015639]clinicaltrials:NCT00031980Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00037791]Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00038311]Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin [clinicaltrials:NCT00039858]Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00039910]Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) [clinicaltrials:NCT00043940]Daclizumab to Treat Chronic Immune Thrombocytopenia [clinicaltrials:NCT00049725]Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) [clinicaltrials:NCT00073580]clinicaltrials:NCT00074165clinicaltrials:NCT00075387AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [clinicaltrials:NCT00102323]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [clinicaltrials:NCT00102336]SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy [clinicaltrials:NCT00102726]SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [clinicaltrials:NCT00110799]clinicaltrials:NCT00116688Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children [clinicaltrials:NCT00118664]clinicaltrials:NCT00128713Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma [clinicaltrials:NCT00151866]A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia [clinicaltrials:NCT00194987]The HIT-TRAP Trial [clinicaltrials:NCT00196417]A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients [clinicaltrials:NCT00198575]Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia [clinicaltrials:NCT00198588]A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia [clinicaltrials:NCT00220311]Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [clinicaltrials:NCT00239733]clinicaltrials:NCT00244010clinicaltrials:NCT00260689Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days [clinicaltrials:NCT00261924]Safety and Performance of MIRASOLĀ® PRT Treated Platelet Transfusion Products [clinicaltrials:NCT00263809]Heparin Antibodies in Intensive Care Unit Patients (HAICU) [clinicaltrials:NCT00283322]clinicaltrials:NCT00283439
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Thrombocytopenia [clinicaltrials_resource:78f621b96ba366d93bd454d319499b20]
Bio2RDF identifier
78f621b96ba366d93bd454d319499b20
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:78f621b96ba366d93bd454d319499b20
identifier
clinicaltrials_resource:78f621b96ba366d93bd454d319499b20
title
Thrombocytopenia
@en
type
label
Thrombocytopenia [clinicaltrials_resource:78f621b96ba366d93bd454d319499b20]
@en
Thrombocytopenia